(NU/1433-40) Transdermal Drug Delivery: The Provision of Business Consultancy to Assist Commercialisation of University Research.
What the buyer wrote
The Northumbria University team have developed a new technology to move drugs into the body from a layer in a patch stuck to the skin. This is an alternative to using needles. Current drug delivery patches don’t work for a large proportion of drugs because of their chemistry characteristics mean they don’t absorb through skin well. This technology can move ‘difficult’ molecules through the skin. The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; a. Act for the company in the spin-out legal process and address all company formation matters; b. Provide to the appropriate university all matters necessary for …
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- (NU/1433-40) Transdermal Drug Delivery: The Provision of Business Consultancy to Assist Commercialisation of University Research.
- How they are buying
- Advertised, shortlist firstSuppliers applied to be considered, and the buyer picked who went on to bid.
- Type
- services
- Dynamic market
- Yes: you can apply to join at any time. How these work
- Where
- in the North East
- Kind of work
- Professional services
Who the buyer named
The buyer published a contact address on this notice.
